BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 8, 2019
View Archived Issues
CD16-IL-15-CLEC12A TriKE demonstrates preclinical activity in models of AML
Read More
PTMs affect, as well as are affected by, protein folding
Read More
Gut-derived plasma cells suppress MS
Read More
Discontinuing tumor treatment can push cells into temporary retirement
Read More
BlackThorn Therapeutics offers pipeline update
Read More
BCAR3 as novel biomarker of prognosis in patients with multiple myeloma
Read More
Final safety results presented from phase I study of BT-11 in healthy volunteers
Read More
SH-498 presented as a promising anti-BMI-1 compound for colorectal cancer
Read More
Incyte begins phase I study of INCB-086550 in advanced solid tumors
Read More
Homology Medicines nominates in vivo gene editing development candidate for PKU
Read More
Epclusa approved in Japan for HCV
Read More
Forbius initiates phase I trial of AVID-200 in solid tumors
Read More
Etrasimod demonstrates long-term clinical remission in phase II OLE study for ulcerative colitis
Read More
Phase III study of SAGE-217 in postpartum depression meets primary and secondary endpoints
Read More
ProQR agrees with FDA on phase II/III trial design for QR-110 in Leber's congenital amaurosis 10
Read More
LINC00165 shown to promote progression of gastric cancer
Read More
FDA clears PrimeVax's IND for first-in-human trial in melanoma
Read More
FDA accepts IND for bispecific antibody MCLA-145
Read More
ContraFect reports topline phase II results for exebacase in S. aureus bacteremia
Read More
Promising phase II data presented for AK-002 in Xolair-naive chronic spontaneous urticaria patients
Read More
Minnebro approved in Japan for hypertension
Read More
Universite Laval patents IL-6 expression inhibitors
Read More
Quretech Bio AB and Washington University present new antibacterials
Read More
Novartis AG discloses new compounds for protozoal infections
Read More
Phase II ASCEND study of AXS-05 in major depressive disorder meets primary endpoint
Read More
Zhejiang Hisun Pharmaceutical describes ACC inhibitors
Read More
CIMA presents new compounds for cancer
Read More
